Business Wire

International Experts Commend Riyadh’s Lifestyle Transformation Projects

Share

A panel of prominent International experts from various academic and professional fields convened yesterday to discuss Riyadh’s USD23 billion investment in the recently announced 4 Grand Projects that will transform the city and improve the wellbeing of millions of citizens in the capital city.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190505005026/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Group picture of the international experts attending Riyadh’s Lifestyle Transformation Forum (Photo: AETOSWire)

The Subject Matter Expert (SME) Forum took place at the Exhibition Centre King Fahad Library Plaza on 1st and 2nd May 2019. Discussion centered on a number of topics, including sustainable urban development, conservation, socio-economic well-being, art and culture, and the facilitation of a healthy lifestyle for all citizens.

The 4 Wellbeing Projects will greatly improve Saudis’ way of life by providing a greener, healthier environment and by encouraging participation in cultural and sporting life, in line with the Kingdom’s Vision 2030. These four projects are part of a massive development plan for the capital Riyadh, highlighting the Kingdom's leadership in sustainable urbanization and environmental management.

The Projects are: King Salman Park – one of the world’s largest urban parks with a land area of 13 km2, roughly four times that of Central Park in New York. The park, in addition to its large green spaces, will include a national theatre, opera house and art academy, and will host entertainment, environmental and cultural events. Green Riyadh – an urban greening project that will reduce CO2 levels and cool the city by up to 2°C. Green Riyadh will see 7.5 million trees planted in gardens, parks, mosques, schools and around the capital’s governmental and health sectors. Riyadh Art – a citywide gallery that will include 1,000 works of art and interactive installations, placed in residential areas, public parks, transport facilities and on Riyadh’s roads. Sports Boulevard – the first of its kind in the region, will feature 135 km of multi-purpose track for walking, running, cycling and horse riding.

“What I’ve seen over these two days is very much at the cutting edge and redefines what a city could be. What Riyadh is doing here I haven’t seen anywhere else in the world – where the planning is so integrated and well thought through, and innovative thinking is so evident. Riyadh is setting the standard. I commend these 4 Grand Projects,” John Rossant, Chairman & Founder, New Cities Foundation.

“Every one of these Wellbeing Projects is quite extraordinary. Riyadh will be transformed in ways that you and I can’t fully understand. They will transform this city not just in its infrastructure and facilities, but will transform health, culture and the very way citizens live their lives,” said Dr. David Griggs, Professor, Sustainable Development Institute, Monash University.

“The scale of these city projects is really impressive. Planting a few trees is nice. Maybe planting a couple of blocks is worthy. But it’s only when you get to the scale of 7.5 million trees and 9% green coverage of the city that you can actually change the climate and cool the city down,” John Englander, Oceanographer & Author, commenting on the 7.5 million trees that will be planted as part of the Riyadh Green Project.

www.riyadhksp.sa/en/

www.riyadhalmasar.sa/en/

www.riyadhart.sa/en/

www.riyadhgreen.sa/en/

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Riyadh Development Authority
Riyadh, Kingdom of Saudi Arabia
Arch. Khalid Al-Hazani, Director, Architectural Projects Program & Public Affairs
+966544777772, hazzani@ada.gov.sa

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release

Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye